A Phase 1b/2 Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 03 Oct 2012
At a glance
- Drugs Gemcitabine; Varlitinib
- Indications Pancreatic cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 05 Apr 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 05 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.